AMANDA NIXON: Open Payments
NPI 1912250861 · TUSTIN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 17 payments from 7 companies in 2025. Trend: 2023 $300 · 2024 $269 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Exact Sciences Corporation | 2 | $35 |
| PFIZER INC. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: VRAYLAR, AIRSUPRA, CAPLYTA, ELIQUIS, REXULTI, The Cologuard Plus Collection Kit, UBRELVY, FARXIGA.
Industry payments across MI — which companies pay providers there.
